Moreira DM, Aronson WJ, Terris MK, Kane CJ, Amling CL, Cooperberg MR, Boffetta P and Freedland SJ. Cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration‐resistant prostate cancer, and mortality after radical prostatectomy. Cancer. 2014;120:197–204.

Abstract

NIH Public Access Author Manuscript Cancer. Author manuscript; available in PMC 2015 January 15. NIH-PA Author Manuscript Published in final edited form as: Cancer. 2014 January 15; 120(2): 197–204. doi:10.1002/cncr.28423. Cigarette Smoking Is Associated With an Increased Risk of Biochemical Disease Recurrence, Metastasis, Castration- Resistant Prostate Cancer, and Mortality After Radical Prostatectomy: Results From the SEARCH Database Daniel M. Moreira, MD 1 , William J. Aronson, MD 2,3 , Martha K. Terris, MD 4,5 , Christopher J. Kane, MD 6 , Christopher L. Amling, MD 7 , Matthew R. Cooperberg, MD 8,9,10 , Paolo Boffetta, MD 11 , and Stephen J. Freedland, MD 12,13,14 1 The NIH-PA Author Manuscript Arthur Smith Institute for Urology, North Shore Long Island Jewish Health System, New Hyde Park, New York 2 Urology Section, Department of Surgery, Veterans Affairs Medical Center of Greater Los Angeles, Los Angeles, California 3 Department of Urology, University of California at Los Angeles Medical Center, Los Angeles, California 4 Urology Section, Division of Surgery, Veterans Affairs Medical Center, Augusta, Georgia 5 Division of Urologic Surgery, Department of Surgery, Medical College of Georgia, Augusta, Georgia 6 Division of Urology, Department of Surgery, University of California at San Diego Medical Center, San Diego, California 7 Division of Urology, Department of Surgery, Oregon Health and Science University, Portland, Oregon NIH-PA Author Manuscript 8 Department of Urology, University of California at San Francisco, San Francisco, California 9 Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, California 10 Urology Section, Department of Surgery, Veterans Affairs Medical Center, San Francisco, California 11 Institute for Translational Epidemiology and Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York © 2013 American Cancer Society. Corresponding author: Daniel M. Moreira, MD, The Arthur Smith Institute for Urology, North Shore Long Island Jewish Health System, 450 Lakeville Rd, New Hyde Park, NY 11042; Fax: (516) 734-8537; dmoreira@nshs.edu. The views and opinions of, and endorsements by, the author(s) do not reflect those of the US Army or the Department of Defense. CONFLICT OF INTEREST DISCLOSURES The authors made no disclosures.